259 results
DEFA14A
LXRX
Lexicon Pharmaceuticals Inc
26 Mar 24
Additional proxy soliciting materials
7:06am
Statement
(as permitted by Rule 14a-6(e)(2))
Definitive Additional Materials
Soliciting Material Pursuant to Rule 14a-11(c)or Rule 14a-12
LEXICON … materials: N/A
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
8-K
EX-10.1
yd0o 25l7ps9h59g585b
11 Mar 24
Lexicon Pharmaceuticals Reports Fourth Quarter 2023
7:26am
8-K
EX-1.1
rxm5hawaxa1
29 Dec 23
Entry into a Material Definitive Agreement
5:29pm
D
evehko2s
20 Jun 23
$72.22 mm in equity, sold $72.22 mm, 1 investor
4:30pm
8-K
EX-1.1
6i8v a8iyi2l
2 Jun 23
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
4:31pm
424B5
dfq18g0tgv6i helb6g
1 Jun 23
Prospectus supplement for primary offering
9:08pm
424B5
nt7vypzzfd1odk
31 May 23
Prospectus supplement for primary offering
4:07pm
D
teb8od0
3 Aug 22
$49.32M in equity, sold $42.89M, 2 investors
4:35pm
8-K
EX-1.1
6ds47ks6yp77j
29 Jul 22
Lexicon Announces Proposed Public Offering of Common Stock
5:18pm